The Aβ1–42/Aβ1–40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1–42 alone

被引：0
|
作者：
Constance Delaby
Teresa Estellés
Nuole Zhu
Javier Arranz
Isabel Barroeta
María Carmona-Iragui
Ignacio Illán-Gala
Miguel Ángel Santos-Santos
Miren Altuna
Isabel Sala
M. Belén Sánchez-Saudinós
Laura Videla
Sílvia Valldeneu
Andrea Subirana
Mireia Tondo
Francisco Blanco-Vaca
Sylvain Lehmann
Olivia Belbin
Rafael Blesa
Juan Fortea
Alberto Lleó
Daniel Alcolea
机构：
[1] Institut d’Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau,Sant Pau Memory Unit, Department of Neurology
[2] Universitat Autònoma de Barcelona,Servei de Bioquímica i Biologia Molecular
[3] IRMB,undefined
[4] INM,undefined
[5] Université de Montpellier,undefined
[6] INSERM,undefined
[7] CHU de Montpellier,undefined
[8] Laboratoire de Biochimie-Protéomique clinique,undefined
[9] Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas,undefined
[10] CIBERNED,undefined
[11] Fundació Catalana Síndrome de Down,undefined
[12] Centre Mèdic Down,undefined
[13] Servei de Bioquímica,undefined
[14] Institut d’Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau,undefined
[15] Universitat Autònoma de Barcelona,undefined
[16] Unversitat Autònoma de Barcelona,undefined
[17] Centro de Investigación Biomédica en Red en Diabetes y Enfermedades Metabólicas (CIBERDEM),undefined
来源：
Alzheimer's Research & Therapy | / 14卷
关键词：
Amyloid; Aβ1–40; Aβ1–42; Cerebrospinal fluid; Tau; Biomarkers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 alone
    Delaby, Constance
    Estelles, Teresa
    Zhu, Nuole
    Arranz, Javier
    Barroeta, Isabel
    Carmona-Iragui, Maria
    Illan-Gala, Ignacio
    Santos-Santos, Miguel Angel
    Altuna, Miren
    Sala, Isabel
    Sanchez-Saudinos, M. Belen
    Videla, Laura
    Valldeneu, Silvia
    Subirana, Andrea
    Tondo, Mireia
    Blanco-Vaca, Francisco
    Lehmann, Sylvain
    Belbin, Olivia
    Blesa, Rafael
    Fortea, Juan
    Lleo, Alberto
    Alcolea, Daniel
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [2] CSF Extracellular Vesicle Aβ42 and Tau/Aβ42 Ratio Are Associated with Cognitive Impairment in Older People with HIV
    Guha, Debjani
    Misra, Vikas
    Chettimada, Sukrutha
    Yin, Jun
    Gabuzda, Dana
    VIRUSES-BASEL, 2024, 16 (01):
  • [3] CSF-Tau and CSF-Aβ1-42 in Posterior Cortical Atrophy
    Baumann, Thomas P.
    Duyar, Hueseyin
    Sollberger, Marc
    Kuhle, Jens
    Regeniter, Axel
    Gomez-Mancilla, Baltazar
    Schmidtke, Klaus
    Monsch, Andreas U.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2010, 29 (06) : 530 - 533
  • [4] CSF Aβ1-42, but not p-Tau181, differentiates aMCI from SCI
    Rizzi, Liara
    Portal, Marcelle Maria
    Alves Batista, Carlos Eduardo
    Missiaggia, Luciane
    Roriz-Cruz, Matheus
    BRAIN RESEARCH, 2018, 1678 : 27 - 31
  • [5] Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42/Aβ1-40 ratio - a cross-validation study against amyloid PET
    Pannee, Josef
    Portelius, Erik
    Minthon, Lennart
    Gobom, Johan
    Andreasson, Ulf
    Zetterberg, Henrik
    Hansson, Oskar
    Blennow, Kaj
    JOURNAL OF NEUROCHEMISTRY, 2016, 139 (04) : 651 - 658
  • [6] Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau
    Lewczuk, P
    Esselmann, H
    Otto, M
    Maler, JM
    Henkel, AW
    Henkel, MK
    Eikenberg, O
    Antz, C
    Krause, WR
    Reulbach, U
    Kornhuber, J
    Wiltfang, J
    NEUROBIOLOGY OF AGING, 2004, 25 (03) : 273 - 281
  • [7] Tau pathogenesis is promoted by Aβ1-42 but not Aβ1-40
    Hu, Xiaoyan
    Li, Xiaoling
    Zhao, Mingrui
    Gottesdiener, Andrew
    Luo, Wenjie
    Paul, Steven
    MOLECULAR NEURODEGENERATION, 2014, 9 : 52
  • [8] Tau pathogenesis is promoted by Aβ1-42 but not Aβ1-40
    Xiaoyan Hu
    Xiaoling Li
    Mingrui Zhao
    Andrew Gottesdiener
    Wenjie Luo
    Steven Paul
    Molecular Neurodegeneration, 9
  • [9] Plasma p-tau181/Aβ1-42 ratio predicts Aβ-PET status and correlates with CSF-p-tau181/Aβ1-42 and future cognitive decline
    Fowler, Christopher J.
    Stoops, Erik
    Rainey-Smith, Stephanie R.
    Vanmechelen, Eugeen
    Vanbrabant, Jeroen
    Dewit, Nele
    Mauroo, Kimberley
    Maruff, Paul
    Rowe, Christopher C.
    Fripp, Jurgen
    Li, Qiao-Xin
    Bourgeat, Pierrick
    Collins, Steven J.
    Martins, Ralph N.
    Masters, Colin L.
    Doecke, James D.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2022, 14 (01)
  • [10] Amyloid β peptide ratio 42/40 but not Aβ42 correlates with phospho-Tau in patients with low- and high-CSF Aβ40 load
    Wiltfang, Jens
    Esselmann, Hermann
    Bibl, Mirko
    Huell, Michael
    Hampel, Harald
    Kessler, Holger
    Froelich, Lutz
    Schroeder, Johannes
    Peters, Oliver
    Jessen, Frank
    Luckhaus, Christian
    Perneczky, Robert
    Jahn, Holger
    Fiszer, Magdalena
    Maler, Juan Manuel
    Zimmermann, Ruediger
    Bruckmoser, Ralf
    Kornhuber, Johannes
    Lewczuk, Piotr
    JOURNAL OF NEUROCHEMISTRY, 2007, 101 (04) : 1053 - 1059
12345